← Open Payments lookup

KANDACE BULLAJIAN: Open Payments

NPI 1033306303 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$568 in 23 payments from 11 companies in 2025. Trend: 2023 $391 · 2024 $619 · 2025 $568

Food & beverage: $568
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.3$173
Radius Health, Inc.4$95
PFIZER INC.4$69
Otsuka America Pharmaceutical, Inc.3$55
Amgen Inc.2$32
Averitas Pharma Inc.1$31
Novo Nordisk Inc2$31
ABBVIE INC.1$27
Lundbeck LLC1$27
Dexcom, Inc.1$15

Products named: GEMTESA, Tymlos, REXULTI, PREVNAR 20, OTEZLA, QUTENZA, QULIPTA, Ozempic.

Industry payments across TX — which companies pay providers there.